Kayne Anderson Rudnick Investment Management LLC Bio Rad Laboratories, Inc. Transaction History
Kayne Anderson Rudnick Investment Management LLC
- $43.7 Billion
- Q3 2024
A detailed history of Kayne Anderson Rudnick Investment Management LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Kayne Anderson Rudnick Investment Management LLC holds 135 shares of BIO stock, worth $46,491. This represents 0.0% of its overall portfolio holdings.
Number of Shares
135
Previous 135
-0.0%
Holding current value
$46,491
Previous $36,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BIO
# of Institutions
458Shares Held
18.2MCall Options Held
19.5KPut Options Held
13.9K-
Vanguard Group Inc Valley Forge, PA1.91MShares$657 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$534 Million0.01% of portfolio
-
Van Eck Associates Corp1.3MShares$449 Million0.55% of portfolio
-
Veritas Asset Management LLP1.09MShares$374 Million3.03% of portfolio
-
First Eagle Investment Management, LLC713KShares$246 Million0.5% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.48B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...